Luteal blood flow in patients undergoing GnRH agonist long protocol

Table 3 Corpus luteum-related CL-RI in the treatment groups

Corpus luteum-resistance index (CL-RI) was measured in each corpus luteum of the patient during the mid-luteal phase in the control group, HCG group, and vitamin E group. The table summarizes the data in Figure 1. The value shows the mean ± SEM from the CL-RI of each corpus luteum. In this study, when CL-RI was more than 0.51, the corpus luteum was evaluated as having decreased blood flow.
a; p < 0.01 v.s. control (Kruskal-Wallis test followed by the Mann-Whitney U-test using the Bonferroni correction). b; p < 0.01 v.s. control (x²-test with Bonferroni correction).

ISSN: 1757-2215